BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38537674)

  • 1. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
    Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
    Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.
    Wang H; Cheng W; Hu P; Ling T; Hu C; Chen Y; Zheng Y; Wang J; Zhao T; You Q
    Front Immunol; 2024; 15():1335112. PubMed ID: 38476236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
    Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis.
    Wang L; He W; Wang X; Wang J; Wei X; Wu D; Wu Y
    Front Med (Lausanne); 2024; 11():1322102. PubMed ID: 38606153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
    Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
    Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.
    Bao H; Li J; Zhang B; Huang J; Su D; Liu L
    Front Immunol; 2023; 14():1113634. PubMed ID: 37090698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
    Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
    Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel immune infiltration-related diagnostic model for Alzheimer's disease using bioinformatic strategies.
    Zhuang X; Zhang G; Bao M; Jiang G; Wang H; Li S; Wang Z; Sun X
    Front Immunol; 2023; 14():1147501. PubMed ID: 37545529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis.
    Mo S; Wang Y; Yuan X; Wu W; Zhao H; Wei H; Qin H; Jiang H; Qin S
    Front Cardiovasc Med; 2023; 10():1142296. PubMed ID: 37063958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm.
    Ji W; An K; Wang C; Wang S
    Hereditas; 2022 Oct; 159(1):38. PubMed ID: 36195955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.
    Jiang H; Hu Y; Zhang Z; Chen X; Gao J
    Lipids Health Dis; 2023 Sep; 22(1):150. PubMed ID: 37697333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease.
    Liu C; Fang Z; Yang K; Ji Y; Yu X; Guo Z; Dong Z; Zhu T; Liu C
    J Cell Mol Med; 2024 Feb; 28(3):e18091. PubMed ID: 38169083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis.
    Xu J; Gou S; Huang X; Zhang J; Zhou X; Gong X; Xiong J; Chi H; Yang G
    Curr Alzheimer Res; 2023; 20(9):618-635. PubMed ID: 38141185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.
    Chu Y; Yu F; Wu Y; Yang J; Shi J; Ye T; Han D; Wang X
    BMC Med Genomics; 2022 Jul; 15(1):150. PubMed ID: 35790963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease.
    Nazari E; Khalili-Tanha G; Asadnia A; Pourali G; Maftooh M; Khazaei M; Nasiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Sci Rep; 2023 Nov; 13(1):20489. PubMed ID: 37993474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of diagnostic genes for both Alzheimer's disease and Metabolic syndrome by the machine learning algorithm.
    Li J; Zhang Y; Lu T; Liang R; Wu Z; Liu M; Qin L; Chen H; Yan X; Deng S; Zheng J; Liu Q
    Front Immunol; 2022; 13():1037318. PubMed ID: 36405716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.
    Luo Z; Yan S; Chao Y; Shen M
    Heliyon; 2024 Apr; 10(7):e28935. PubMed ID: 38601640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies.
    Zhang Z; Wang S; Zhu Z; Nie B
    Comput Biol Med; 2023 May; 157():106724. PubMed ID: 36898287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning.
    Lai Y; Lin P; Lin F; Chen M; Lin C; Lin X; Wu L; Zheng M; Chen J
    Front Immunol; 2022; 13():1046410. PubMed ID: 36569892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
    He R; Guan C; Zhao X; Yu L; Cui Y
    Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.